Software-guided insulin dosing: Tight glycemic control and decreased glycemic derangements in critically ill patients

Mayo Clinic Proceedings

Volumn 88, Issue 9, 2013, Pages 920-929

  Saur, Nicole M ^a,c   Kongable, Gail L ^d   Holewinski, Sharon ^b   O'Brien, Keri ^b   Nasraway Jr , Stanley A ^a,c  

^a TUFTS MEDICAL CENTER   (United States)

^b Department of Nursing ^*  (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Epsilon Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE METER; CLINICAL PROTOCOL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PROSPECTIVE STUDY;

EID: 84884652209     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.07.003     Document Type: Article

References (57)

1. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009; 37(12): 3001-3009.
2. Bagshaw SM, Egi M, George C, Bellomo R; Australia New Zealand Intensive Care Society Database Management Committee. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37(2): 463-470.
3. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19): 1359-1367.
4. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5): 449-461.
5. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663): 547-556.
6. Nasraway SA, Rattan R. Tight glycemic control: what do we really know, and what should we expect? Crit Care. 2010; 14(5):198.
7. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a metaanalysis including NICE-SUGAR study data. CMAJ. 2009; 180(8): 821-827.
8. Finfer S, Liu B, Chittock DR, et al; NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12): 1108-1118.
9. Krinsley JS. Glycemic variability: a strong independent risk factor for mortality in critically ill patients. Crit Care Med. 2008;36(11): 3008-3013.
10. Mackenzie IMJ, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intensive Care Med. 2011; 37(3): 435-443.
11. Krinsley JS. Glycemic variability in critical illness and the end of Chapter 1. Crit Care Med. 2010;38(4): 1206-1208.
12. Umpierrez GE, Smiley D. Time-dependent glycemic variability and mortality in critically ill patients with diabetes. Crit Care Med. 2011;39(1): 211-213.
13. Dumont C, Bourguignon C. Effect of a computerized insulin dose calculator on the process of glycemic control. Am J Crit Care. 2012;21(2): 106-115.
14. Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17(2):R37.
15. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation for severe sepsis. N Engl J Med. 2008;358(2): 125-139.
16. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10): 1738-1748.
17. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360(13): 1283-1297.
18. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12): 2778-2785.
19. Van den Berghe G, Schetz M, Vlasselaers D, et al. Clinical review: intensive insulin therapy in critically ill patients: NICE SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9): 3163-3170.
20. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15(4): 370-377.
21. Oeyen SG, Hoste EA, Roosens CD, Decruyenaere JM, Blot SI. Efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care. 2007;16(6): 599-608.
22. Cyrus RM, Szumita PM, Greenwood BC, Pendergrass ML. Evaluation of compliance with a paper-based, multiplication-factor, intravenous insulin protocol. Ann Pharmacother. 2009;43(9): 1413-1418.
23. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10): 2262-2267.
24. NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12): 1108-1118.
25. Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5): 1107-1110.
26. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15): 2041-2047.
27. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2): 244-252.
28. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM Jr, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg. 2008;74(8): 679-685.
29. Ali NA, O'Brien JM Jr, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8): 2316-2321.
30. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38(4): 1021-1029.
31. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3): 838-842.
32. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13(3):R91.
33. Pretty CG, Le Compte AJ, Chase GJ, et al. Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control. Ann Intensive Care. 2012;2(1):17.
34. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 2009; 3(6): 1292-1301.
35. Van Herpe T, De Brabanter J, Beullens M, De Moor B, Van den Berghe G. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Crit Care. 2008;12(1): 1-14.
36. Service FJ, MolnarGD, Rosevear JW, Ackeerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9): 644-655.
37. Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3): 232-240.
38. Newton CA, Smiley D, Bode BW, et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med. 2010;5(8): 432-437.
39. Juneja R, Roudebush CP, Nasraway SA, et al. Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Crit Care. 2009;13(5):R163.
40. Nasraway SA. Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr. 2006;30(3): 254-258.
41. Cook CB, Moghissi E, Joshi R, Kongable GL, Abad VJ. Inpatient point-of-care bedside glucose testing: preliminary data on use of connectivity informatics to measure hospital glycemic control. Diabetes Technol Ther. 2007;9(6): 493-500.
42. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10): 818-829.
43. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281(5):E924-E930.
44. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52(11): 2795-2804.
45. Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5): 1349-1354.
46. Nazar LH, Chow SL, Moghissi ES. Insulin infusion protocols for critically ill patients: a highlight of differences and similarities. Endocr Pract. 2007;13(2): 137-146.
47. Wittenberg MD, Gattas DJ, Ryan A, Totaro R. Introduction of intensive glycaemic control into a neurosurgical intensive care unit: a retrospective cohort study. Crit Care Resusc. 2008; 10(3): 203-208.
48. Thompson BT, Orme JF, Zheng H, et al. Multicenter validation of a computer-based clinical decision support tool for glucose control in adult and pediatric intensive care units. J Diabetes Sci Technol. 2008;2(3): 357-368.
49. Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak. 2005;5:38.
50. Evans A, Le Compte A, Tan C-S, et al. Stochastic targeted (STAR) glycemic control: design, safety, and performance. J Diabetes Sci Technol. 2012;6(1): 102-115.
51. Van den Berghe G. Intensive insulin therapy in the ICU: reconciling the evidence. Nat Rev Endocrinol. 2012;8(6): 374-378.
52. Cook CB, Abad V, Kongable G, Hansweon Y, McMahon D. The status of glucose control in U.S. intensive care units [abstract]. Crit Care Med. 2008;36:sA68.
53. Lonergan T, Le Compte A, Willacy M, et al. A simple insulinnutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8(2): 191-206.
54. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in the setting targets for inpatient management. Diabetes Care. 2007;30(2): 403-409.
55. Desachy A, Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc. 2008;83(4): 400-405.
56. Meynaar IA, van Spreuwel M, Tangkau PL, et al. Accuracy of AccuCheck glucose measurement in intensive care patients. Crit Care Med. 2009;37(10): 2691-2696.
57. Cook CB, Wellik KE, Kongable GL, Shu J. Assessing inpatient glycemic control: what are the next steps? J Diabetes Sci Technol. 2012;6(2): 421-427.